National Cancer Institute Home at the National Institutes of Health | www.cancer.gov

Spotlight on Applied Research

Recent Meetings & Training Opportunities

PROSPR Reviews Progress, Outlines New Collaborative Projects

The September 2013 scientific meeting of the Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) initiative brought together staff from the NCI, the PROSPR Research Centers, and the PROSPR Statistical Coordinating Center. The overall aim of PROSPR is to conduct multi-site, coordinated, transdisciplinary research to evaluate and improve cancer screening processes. The seven PROSPR research centers reflect the diversity of US delivery system organizations.

At the meeting, the group discussed the progress that has been made over the first two years of the grant, as well as future directions for years three through five. Specifically, the group focused on plans for collaborative projects that would take advantage of the breadth of resources and knowledge across multiple research centers and cancer sites. The breast, cervical, and colorectal working groups met individually to discuss their goals and challenges, as did the Health Disparities and Process Measures working groups.

The PROSPR organizational chart reflects recent shifts in roles, with Dr. Ann Geiger serving as Lead Scientific Advisor, Dr. Carrie Klabunde as Project Scientist for the breast and colorectal working groups, and Ms. Julia Strasser providing project support. Dr. Paul Doria-Rose (Project Scientist for the cervical working group) and Ms. Anita Ambs (PROSPR Program Director) remain in their roles.

Implementation of the Affordable Care Act highlights the importance and timeliness of the PROSPR initiative's work. As explained by Dr. Geiger: "By increasing the number of insured individuals and requiring coverage of proven screening tests at no cost to the individual, the Affordable Care Act is expected to add stress to an already stretched and fragmented U.S. health care delivery system. Thus, it is imperative that we identify individuals most likely to benefit from cancer screening and create efficient processes to ensure that screened individuals receive high-quality and timely care. PROSPR is uniquely positioned to contribute to this effort given their access to patient, provider, and facility data from a set of institutions that reflect the complexity of medical care in our country."

Last Modified: 31 Dec 2013